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Proteases commit microbicide
 
hite blood cells use proteases to kill their targets, according 
to new results from Emer Reeves, Hiu Lu, Anthony Segal 
(University College, London, England), and colleagues. The 
findings contradict previously accepted notions that reactive 
oxygen species (ROSs) are the killing agents.
ROSs like superoxide are produced by NADPH oxidase 
activity when white blood cells, primarily neutrophils, 
phagocytose pathogens. For decades it has been thought that 
high concentrations of the toxic ROSs resulting from this 
respiratory burst are directly responsible for killing micro-
organisms. But the new results prove otherwise.
Segal’s group showed that mice deficient in protease activity 
have increased sensitivity to microbes. Additionally, purified 
neutrophils from the protease-deficient mice are impaired in 
their antimicrobial activity in vitro. “Our results are conclusive,” 
says Segal. “By taking out the proteases, we do not interfere 
with the respiratory burst, but do interfere with killing.”
The proteases are activated 
through increases in both pH 
and hypertonicity in the 
phagocytotic vacuoles. These 
changes arise when NADPH 
oxidase activity drives electrons 
into the vacuole. To compensate 
for the charge transfer across the 
membrane, K
 
 
 
 also enters. The 
resulting hypertonic conditions 
release the cationic proteases 
from their bound state on an 
anionic proteoglycan matrix. K
 
 
 
 entry also results in alkaline 
conditions that stimulate protease activity. The proteases are 
then free to bind to and digest the target microbes.
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Neutrophils kill engulfed 
microbes (white) using 
proteases.
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Trafﬁc jam suppresses immunity
 
rgan rejection in transplant patients can be prevented using 
the drug FTY720, but the drug’s mechanism of action has 
been unknown. Now, Suzanne Mandala, Hugh Rosen, and 
colleagues (Merck Research Laboratories, Rahway, NJ) show 
that it acts by retaining lymphocytes in lymph nodes, preventing 
their circulation through the bloodstream.
 
 
 
B and T lymphocytes are either 
retained in lymph nodes in order 
to contact antigens and antigen-
presenting cells or sent back out into 
the bloodstream for circulation. 
Circulating lymphocytes may enter 
tissues, where they mediate protective 
activities or cause tissue damage. 
Most immunosuppressive drugs 
work by inhibiting lymphocyte 
function: they either kill the cells directly, inhibit their production, 
or block signals downstream of antigen recognition. But FTY720 
works in a novel manner.
Rosen’s group found that a phosphate ester metabolite of 
FTY720 mimics the natural lipid sphingosine-1-phosphate 
(S1P) and binds several forms of S1P receptors. Activation of the 
receptors causes the sequestration of lymphocytes at nodes and a 
corresponding decrease in circulating lymphocytes. “This is the 
first indication that S1P and its receptors regulate lymphocyte 
trafficking and that, if manipulated pharmacologically, [they] 
can give rise to immunosuppression,” says Rosen. Unlike S1P, 
the side effects of which include low blood pressure, FTY720 is 
better tolerated in clinical use. The reasons behind this distinction 
are yet unclear, but may involve the failure of FTY720 to bind all 
S1P receptors. 
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FTY720 causes lympho-
cytes to get trapped in 
nodes (bracket).
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Learning by palmitoylation
 
earning is probably driven by use-
dependent changes in synaptic 
strength. Now, Alaa El-Husseini, David 
Bredt (University of California at San 
Francisco, San Francisco, CA), and 
colleagues have identified regulated protein 
palmitoylation as one means to control 
the strength of synapse responses.
Synaptic activity is controlled by 
AMPA channels, which respond to the 
neurotransmitter glutamate by letting in 
Na
 
 
 
 until the neuron fires. Ca
 
2
 
 
 
 influx 
through NMDA receptors (also activated 
by glutamate) alters synaptic responses by 
influencing the number of AMPA receptors 
clustered at the synapse.
It now appears that protein palmitoylation 
is key to this modulation. The localization 
L
 
of AMPA receptors is controlled by the 
PDZ domain protein PSD-95, which also 
clusters at synapses and binds to the AMPA-
trafficking protein stargazin. The clustering 
of PSD-95 is known to require its 
palmitoylation. Now, Bredt and colleagues 
demonstrate that increased glutamate
receptor activity accelerates depalmitoylation 
of PSD-95 and that depalmitoylation 
causes endocytosis and dispersion of both 
PSD-95 and AMPA receptors, leading to 
depression of synaptic strength.
“This defines a mechanism for activity-
dependent changes in AMPA receptor 
numbers and defines protein palmitoylation 
as a new signaling mechanism at 
synapses,” says Bredt. The enzymes that 
add and remove PSD-95 palmitoyl groups 
have not been identified, but Bredt 
speculates that they will be Ca
 
2
 
 
 
 regulated, 
as Ca
 
2
 
 
 
 entry into the cell (e.g., through 
NMDA receptors) is required for AMPA 
dispersion. 
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Clusters of AMPA receptors (red spots) 
disperse when PSD-95 palmitoylation is 
blocked (right).
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